Drug Overview
Dabitran 75 mg 60 Tablets is a prescription anticoagulant medicine available through United Pharmacy with a valid, recent medical prescription. It contains dabigatran and is used to help prevent harmful blood clots, treat thromboembolic conditions, and reduce clot-related complications in appropriate patients under medical supervision.
Active Ingredient and Composition
The active ingredient in this product is dabigatran.
Each pack contains 75 mg strength and 60 tablets as listed in the source content.
Drug Class
Dabigatran belongs to the class of oral anticoagulants. These medicines are commonly called blood thinners, although they do not actually thin the blood. Instead, they reduce the blood’s tendency to form dangerous clots.
Uses of Dabitran 75 mg 60 Tablets
Dabitran 75 mg 60 Tablets is used for the prevention and treatment of blood clots in selected patients. Reported indications in the source content include:
- Prevention of blood clots
- Treatment of deep vein thrombosis (DVT)
- Treatment of pulmonary embolism (PE)
- Reduction of stroke risk in patients with atrial fibrillation
These uses make it relevant for patients who need long-term or short-term anticoagulation as part of clot-risk management.
How Dabitran 75 mg 60 Tablets Works
Dabitran 75 mg 60 Tablets contains dabigatran, which works as an anticoagulant by interfering with the clotting process, helping to prevent new clots from forming and reducing the chance that existing clots will worsen. This mechanism supports the management of venous thromboembolism and stroke prevention in eligible patients.
Dosage and Administration of Dabitran 75 mg 60 Tablets
The dose should always be determined by the treating physician based on the patient’s condition, treatment goal, and clinical risk factors.
Safe administration guidance includes:
- Take the medicine exactly as prescribed
- Swallow the tablet whole without chewing or breaking it
- Try to take it at the same time every day
- Do not adjust the dose without medical advice
The prescribed regimen may differ depending on whether the medicine is being used for clot prevention or active clot treatment.
Possible Side Effects
Like other anticoagulants, this medicine may cause side effects, especially bleeding-related events. Reported adverse effects include:
- Bleeding, such as gum bleeding, nosebleeds, or gastrointestinal bleeding
- Stomach discomfort or digestive upset
- Anemia in some cases
Any unusual bruising, prolonged bleeding, black stools, vomiting blood, or sudden weakness requires urgent medical attention.
Contraindications
This medicine should not be used in the following situations unless a specialist determines otherwise:
- Active bleeding
- Known allergy or hypersensitivity to dabigatran
- Severe liver disease associated with bleeding risk
Drug Interactions
Potential interactions may occur with:
- Other anticoagulant medicines
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Some antibiotics
- Some antifungal medicines
Because interacting medicines may increase bleeding risk, patients should inform their doctor and pharmacist about all prescription drugs, over-the-counter medicines, and supplements they use.
Warnings and Precautions
- Use with caution in patients with kidney impairment
- Monitor for any signs of abnormal bleeding
- Inform the doctor before any surgery, dental procedure, or invasive intervention
- Continue only under appropriate medical supervision
Patients should not stop anticoagulant therapy suddenly unless instructed by their healthcare provider, because interruption may increase thrombotic risk.
Use During Pregnancy and Breastfeeding
Use during pregnancy or breastfeeding should be evaluated by a physician. Anticoagulant treatment in these situations requires an individualized risk-benefit assessment.
Use for Children
Pediatric use should only occur under specialist medical guidance. Suitability depends on the child’s age, indication, and clinical status.
Drug Alternatives
Alternative anticoagulant options may be considered by the prescribing physician depending on the patient’s diagnosis, renal function, bleeding risk, and treatment plan. Alternatives are not interchangeable without medical review.
Comparison With Similar Drugs
Compared with other anticoagulants, dabigatran is an oral option used for clot prevention and treatment in selected patients. The most appropriate choice depends on clinical indication, patient-specific risks, possible drug interactions, and physician judgment rather than price or convenience alone.
Safe Usage Tips
- Keep follow-up appointments as advised
- Watch for bleeding from the gums, nose, urine, stool, or stomach
- Tell healthcare providers that you are taking an anticoagulant
- Store at room temperature away from heat and moisture
- Keep out of reach of children
Dabitran 75 mg 60 Tablets should always be used responsibly and only with professional medical supervision to support safe and effective clot management.
